Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States
Abstract
Authors
RF Pollock P Johansen B Hunt NN Iyer T Dang-Tan L Wilkinson
RF Pollock P Johansen B Hunt NN Iyer T Dang-Tan L Wilkinson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now